CME and CNE Information « SOHO 2019




CME Certificates and Attendance Verification Certificates

To obtain CME certificate awarding AMA PRA Category 1 Credit™, physicians must submit a completed evaluation questionnaire and a CME Verification form. MD/DO's will receive a certificate awarding AMA PRA Category 1 Credit™. All other healthcare professionals will receive a certificate of participation indicating the number of AMA PRA Category 1 Credit™ approved for this activity.

The CME Verification and Evaluation link will be accessible until Wednesday, October 18, 2019. To submit the CME Verification and Evaluation forms after this date, please contact the Office of CME at 713-792-5357.

The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharrmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.

Agendas are subject to change because we are always striving to improve the quality of your educational experience. MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, scheduling conflicts, and so forth.

Photographing, audiotaping, and videotaping are prohibited.

In order to obtain AMA PRA Category 1 Credit™, record your attendance, and/or evaluate the conference, please click the following link:

Certificates will not be available after October 18, 2019.

Educational Objectives

After participating in the activity, the participant should be able to:

  1. 1. Evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of hematologic malignancies (knowledge, competence, performance).
  2. 2. Debate the benefits of maintenance therapies in patients with hematologic malignancies and integrate key findings into clinical practice to improve patient care (knowledge, competence, performance).
  3. 3. Describe the clinical and molecular facets of biology, pathogenesis, diagnostic approaches and therapeutic modalities available for various hematologic disorders (knowledge, competence).
  4. 4. Apply emerging therapies and novel treatment strategies for patients with hematologic malignancies and evaluate the practical utility of novel agents based on data from recent clinical studies to improve outcomes (knowledge, competence, performance, patient outcomes).
  5. 5. Differentiate the evolving therapeutic strategies for first-line, second-line, third-line, and salvage treatment of hematologic malignancies and apply these strategies into practice (knowledge, competence, performance).

Target Audience

This program is directed towards Physicians, RNs, PAs, PharmDs, Fellows and Students interested in Hematology Oncology, Medical Oncology and Internal Medicine.

Educational Methods

Lectures, Case Studies, Panel Discussions, Poster Session, Poster Presentations, Interactive Small Groups, Question-and-Answer Sessions


A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

Accreditation/Credit Designation

This activity has been planned and implemented in accordance with accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Texas MD Anderson Cancer Center and the Society of Hematologic Oncology. The University of Texas MD Anderson Cancer Center is accredited by the ACCME to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 27.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



This continuing nursing education activity was approved by the Texas Nurses Association - Approver, an accredited approver with distinction, by the American Nurses Credentialing Center’s Commission on Accreditation.

This CNE activity is being jointly provided by The Society of Hematologic Oncology collaboratively with JWC Covenant, Inc.

Learning Outcome

By the end of this conference the learner will know how to identify and apply the latest advances in science, pathophysiology, therapy and appropriate nursing care management for patients with hematologic malignancies, based on current evidence.

Requirements for Successful Completion

1. Attendance at one (1) or more sessions.

2. Complete and submit an evaluation form.

Registered attendees can earn up to 25 contact hours, depending on sessions attended, at the Society of Hematologic Oncology 2019 Annual Meeting.

In order to claim your Contact Hours & Certificate, you will need to go online and complete the Verification and Evaluation Form.

Once this form is submitted you will receive your certificate via email.

Please be sure to check your junk and/or SPAM mail.

You can access the Evaluation Form through the following link:

Enter the following url address into your web browser:

If you have any questions regarding CNE, please feel free to call Belinda Melder at 281-364-7387 ext 201.

The link will be active until Thursday, October 18, 2019.